Pharmacien Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.90 M
- Company Age 10 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 0.25 M
- Revenue Growth 15.55%
- Profit Growth 41.84%
- Ebitda -28.55%
- Net Worth 1.08%
- Total Assets 53.29%
About Pharmacien Life Sciences
Pharmacien Life Sciences Private Limited (PLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 July 2014 and has a history of Ten years and seven months. Its registered office is in Theni, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.90 M.
The company has closed loans amounting to ₹0.25 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Senthilkumar Murugesan, Parameswari Murugesan, and Murugesan Vairavan serve as directors at the Company.
Company Details
-
Location
Theni, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999TN2014PTC096385
-
Company No.
096385
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Jul 2014
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Pharmacien Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Senthilkumar Murugesan
|
Managing Director | 02-Jul-2014 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Parameswari Murugesan
|
Director | 02-Jul-2014 | Current |
|
Murugesan Vairavan
|
Director | 02-Jul-2014 | Current |
Financial Performance of Pharmacien Life Sciences.
Pharmacien Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 15.55% increase. The company also saw a substantial improvement in profitability, with a 41.84% increase in profit. The company's net worth moved up by a moderate rise of 1.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmacien Life Sciences?
In 2020, Pharmacien Life Sciences had a promoter holding of 71.11% and a public holding of 28.89%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Confervo Formulations Private LimitedSenthilkumar Murugesan is a mutual person
-
Behandler Pharmaceuticals Private Limited
Senthilkumar Murugesan is a mutual person
-
Victomed Pharmaceuticals Private Limited
Senthilkumar Murugesan is a mutual person
Charges (Loans)
₹0
₹0.25 M
Charges Breakdown by Lending Institutions
- City Union Bank Limited : 0.03 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Feb 2020 | City Union Bank Limited | ₹0.25 M | Satisfied |
How Many Employees Work at Pharmacien Life Sciences?
Unlock and access historical data on people associated with Pharmacien Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmacien Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmacien Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.